Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2013
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms REPLAY
- Sponsors EMD Serono
- 20 Apr 2012 Data will be presented at the American Academy of Neurology's 64th Annual Meeting (AAN) [posters P04.119; P04.120], according to a Merck Serono media release.
- 08 Mar 2012 Actual patient number (309) added as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual end date (August 2011) added as reported by ClinicalTrials.gov.